The Life Science community includes a wide range of company types from non-profit research & development institutions to large pharmaceutical companies. With this broad spectrum comes different trends in what keeps these companies moving forward to create the next best cure or drug for the world.
One consistent common denominator all life science companies generally share is the impact the US government can have on progress for them. Whether its NIH grants to fund the next cure, or the FDA to pass a new drug making process, the uncertainties and critical milestones steps to get government approvals have a direct impact on how we manage projects for most of our LS clients.
Having some of these types of insights really informs us in developing and managing projects particularly around budget and schedule milestones, as well as the sensitivity of confidential information for practically all of our Life Science projects.